Improvement in Nocturnal Hypoxemia in Obese Patients with Obstructive Sleep Apnea after Bariatric Surgery: a Meta-Analysis

Zhang, Yuxiang; Wang, Wenyue; Yang, Cai‐Rong; Shen, Jian; Shi, Meilong; Wang, Bing

doi:10.1007/s11695-018-3573-5

Cited by 30 publications

(19 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This supports the results observed by El Moussaoui et al [ 9 ] and Vitiello et al [ 10 ]. Therefore, irrespective of the COVID-19 pandemic and lockdown, bariatric surgery remains an effective treatment against diabetes [ 2 , 3 , 22 ], hypertension [ 2 , 3 ], and obstructive sleep apnea [ 2 , 3 , 23 ]. Moreover, bariatric surgery has been marked as a protective factor against COVID-19 with lower hospital admission rate, reduced intensive care unit admission [ 24 ], mechanical ventilation, or exitus [ 25 ].…”

Section: Discussionmentioning

confidence: 99%

Impact of the COVID-19 Pandemic and Lockdown on Gastric Bypass Results at 1-Year Follow-up

et al. 2021

View full text Add to dashboard Cite

Purpose The COVID-19 pandemic caused a lockdown in many countries, which induced negative dietary habits and sedentary behavior. Studies suggest that weight loss of patients undergoing bariatric surgery was equally affected. The aim was to evaluate the impact of COVID-19 on weight loss, obesity-related comorbidities, and nutritional status at 1-year follow-up after gastric bypass (GB). Methods Retrospective observational case–control study of patients undergoing primary GB in a tertiary referral Belgian center. COVID-19 period group was composed by those whose 1-year postoperative period was affected by the COVID-19 pandemic and lockdown: from October 1, 2019, to March 31, 2020. The control group was composed of patients operated from October 1, 2018, to March 31, 2019. Electronic clinical records were reviewed searching: baseline characteristics, weight and comorbidities evolution, and biochemical values. Results A total of 47 patients in the COVID-19 period group and 66 in the non-COVID-19 period group were analyzed. There were no significant differences in baseline characteristics. A reduced weight loss was observed at 1-year follow-up, in terms of percentage of excess weight loss (%EWL) (82.4% [SD: 21.6] vs. 82.4% [SD: 21.6]; p : 0.043) and body mass index (BMI) (27.8 kg/m 2 [IQR: 25.8–30.0] vs. 26.2 kg/m 2 [IQR: 24.6–28.6]; p : 0.029) for COVID-19 period group vs. non-COVID-19 period group, respectively. There was a similar reduction of obesity-related comorbidities, without clinically significant differences in the nutritional follow-up. Conclusion The COVID-19 pandemic and lockdown had an impact on weight loss at 1-year follow-up after gastric bypass. Graphical abstract

show abstract

Section: Discussionmentioning

confidence: 99%

Impact of the COVID-19 Pandemic and Lockdown on Gastric Bypass Results at 1-Year Follow-up

et al. 2021

View full text Add to dashboard Cite

show abstract

“…(208) A cirurgia bariátrica é o tratamento mais eficaz e duradouro para a obesidade, reduzindo o risco de comorbidades relacionadas à obesidade, além de promover melhorias significativas nos eventos respiratórios obstrutivos, na oxigenação e na mortalidade. (209)(210)(211) Em geral, os pacientes obesos mórbidos com AOS e submetidos à cirurgia bariátrica parecem ter maior risco de complicações no peri-e pós-operatórios. (212,213) Após a cirurgia bariátrica, há redução efetiva de peso corporal, com melhora importante da AOS, podendo até atingir a resolução completa da mesma.…”

Section: Outros Tratamentos Além Da Pressão Positivaunclassified

Brazilian Thoracic Association Consensus on Sleep-disordered Breathing

et al. 2022

View full text Add to dashboard Cite

Sleep is essential for the proper functioning of all individuals. Sleep-disordered breathing can occur at any age and is a common reason for medical visits. The objective of this consensus is to update knowledge about the main causes of sleep-disordered breathing in adult and pediatric populations, with an emphasis on obstructive sleep apnea. Obstructive sleep apnea is an extremely prevalent but often underdiagnosed disease. It is often accompanied by comorbidities, notably cardiovascular, metabolic, and neurocognitive disorders, which have a significant impact on quality of life and mortality rates. Therefore, to create this consensus, the Sleep-Disordered Breathing Department of the Brazilian Thoracic Association brought together 14 experts with recognized, proven experience in sleep-disordered breathing.

show abstract

“…obesity-related comorbidities such as diabetes mellitus [6] and obstructive sleep apnea [7]. Two common weight-loss surgeries are roux-en-y gastric bypass (RYGB) and sleeve gastrectomy (SG), both of which can be performed laparoscopically.…”

Section: Key Pointsmentioning

confidence: 99%

Antiretroviral Therapy Efficacy Post-Bariatric Weight Loss Surgery: A Case Series of Persons Living with Human Immunodeficiency Virus

2022

View full text Add to dashboard Cite

Purpose Human immunodeficiency virus (HIV)–related mortality has decreased secondary to advances in antiretroviral therapy (ART), and the incidence of obesity in this population is increasing. Bariatric surgery is an effective method of weight loss, though changes in the gastrointestinal tract may affect ART absorption and virologic suppression. Existing data are limited to case reports studying outdated therapeutic regimens; studies evaluating modern ART regimens are needed. The objective of this study was to determine if undergoing bariatric surgery impacts HIV virologic failure rate at 12 months post-surgery and to characterize the failure population. Materials and Methods This retrospective case series included adults with virologically suppressed HIV on ART who underwent roux-en-y gastric bypass (RYGB) or sleeve gastrectomy (SG) surgery between 2000 and 2019 (n=20) at one of three medical centers within one academic medical system. The primary outcome was proportion of patients with ART failure at 12 months post-surgery. Select additional data collected included CD4+ count, metabolic parameters, postoperative complications, and medication non-adherence. Results A total of 18 patients were included in this analysis. Seventeen of 18 patients (94%) maintained virologic suppression within 12 months post-surgery. There were no significant changes in CD4+ counts before and after surgery. The one failure was an African American woman who underwent sleeve gastrectomy surgery. This patient’s baseline viral load was undetectable and CD4+ count was 263 cells/mm3. Conclusion Undergoing bariatric surgery did not increase virologic failure rate in a small cohort of persons living with HIV, and ART non-adherence was associated with virologic failure. Graphical abstract

show abstract

Improvement in Nocturnal Hypoxemia in Obese Patients with Obstructive Sleep Apnea after Bariatric Surgery: a Meta-Analysis

Cited by 30 publications

References 29 publications

Impact of the COVID-19 Pandemic and Lockdown on Gastric Bypass Results at 1-Year Follow-up

Impact of the COVID-19 Pandemic and Lockdown on Gastric Bypass Results at 1-Year Follow-up

Brazilian Thoracic Association Consensus on Sleep-disordered Breathing

Antiretroviral Therapy Efficacy Post-Bariatric Weight Loss Surgery: A Case Series of Persons Living with Human Immunodeficiency Virus

Contact Info

Product

Resources

About